BriaCell Therapeutics Announces $8.5M Equity Offering (NASDAQ:BCTX)
Wednesday, 11 September 2024, 17:17
BriaCell Therapeutics' Equity Offering Details
BriaCell Therapeutics is set to enhance its financial position through a significant equity offering. The company will issue a total of 12.33 million shares, priced at $0.69 each, aiming to raise $8.5 million for ongoing research and development efforts.
Funding for Oncology Research
This equity offering is pivotal for BriaCell as it continues to advance its cancer research. The funds will bolster clinical trials and support the development of innovative therapies.
- Offering Size: 12.33M shares
- Share Price: $0.69
- Expected Proceeds: $8.5M
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.